Protara Therapeutics Inc (TARA)

NASDAQ
3.67
+0.13(+3.67%)
  • Volume:
    26,043
  • Day's Range:
    3.54 - 3.67
  • 52 wk Range:
    2.72 - 8.63

TARA Overview

Prev. Close
3.47
Day's Range
3.54-3.67
Revenue
-
Open
3.6
52 wk Range
2.72-8.63
EPS
-3.58
Volume
26,043
Market Cap
41.01M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
35,883
P/E Ratio
-0.979
Beta
1.64
1-Year Change
-49.64%
Shares Outstanding
11,267,389
Next Earnings Date
Nov 03, 2022
What is your sentiment on Protara Therapeutics?
or
Vote to see community's results!

Protara Therapeutics Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Protara Therapeutics Inc Analysis

Protara Therapeutics Inc Company Profile

Protara Therapeutics Inc Company Profile

Employees
31

Protara Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying therapies for the treatment of cancer and rare diseases. The Company's pipeline includes TARA-002 and IV Choline Chloride. The Company's lead product pipeline is TARA 002 for the treatment of non-muscle invasive bladder cancer (NMIBC) and Lymphatic Malformations (LMs). TARA 002 is a cellular therapy based on OK-432, also known as Picibanil, which is derived from a genetically distinct strain of Streptococcus Pyogenes. IV choline chloride is an investigational, intravenous (IV) phospholipid substrate replacement therapy, which is in development for patients receiving parenteral nutrition (PN) who have intestinal failure-associated liver disease (IFALD).

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
  • Hoax
    0
    • who is here?
      0
      • Please..
        0
        • Uptrending
          0
          • ?
            0